|
1
|
Tian T, Wang M, Lin S, Guo Y, Dai Z, Liu
K, Yang P, Dai C, Zhu Y, Zheng Y, et al: The impact of lncRNA
dysregulation on clinicopathology and survival of breast cancer: A
systematic review and meta-analysis. Mol Ther Nucleic Acids.
12:359–369. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang X, Qiu W, Zhang G, Xu S, Gao Q and
Yang Z: MicroRNA-204 targets JAK2 in breast cancer and induces cell
apoptosis through the STAT3/BCl-2/survivin pathway. Int J Clin Exp
Pathol. 8:5017–5025. 2015.PubMed/NCBI
|
|
3
|
DeSantis C, Ma J, Bryan L and Jemal A:
Breast cancer statistics, 2013. CA Cancer J Clin. 64:52–62. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Feng W, Wang C, Liang C, Yang H, Chen D,
Yu X, Zhao W, Geng D, Li S, Chen Z and Sun M: The dysregulated
expression of KCNQ1OT1 and its interaction with downstream factors
miR-145/CCNE2 in breast cancer cells. Cell Physiol Biochem.
49:432–446. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bertero T, Cottrill KA, Lu Y, Haeger CM,
Dieffenbach P, Annis S, Hale A, Bhat B, Kaimal V, Zhang YY, et al:
Matrix remodeling promotes pulmonary hypertension through feedback
mechanoactivation of the YAP/TAZ-miR-130/301 circuit. Cell Rep.
13:1016–1032. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cai H, Xu J, Han Y, Lu Z, Han T, Ding Y
and Ma L: Integrated miRNA-risk gene-pathway pair network analysis
provides prognostic biomarkers for gastric cancer. Onco Targets
Ther. 9:2975–2986. 2016.PubMed/NCBI
|
|
8
|
Batista PJ and Chang HY: Long noncoding
RNAs: Cellular address codes in development and disease. Cell.
152:1298–1307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hsieh IS, Chang KC, Tsai YT, Ke JY, Lu PJ,
Lee KH, Yeh SD, Hong TM and Chen YL: MicroRNA-320 suppresses the
stem cell-like characteristics of prostate cancer cells by
downregulating the Wnt/beta-catenin signaling pathway.
Carcinogenesis. 34:530–538. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang T, Zou P, Wang T, Xiang J, Cheng J,
Chen D and Zhou J: Down-regulation of miR-320 associated with
cancer progression and cell apoptosis via targeting Mcl-1 in
cervical cancer. Tumour Biol. 37:8931–8940. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gooding AJ, Zhang B, Jahanbani FK, Gilmore
HL, Chang JC, Valadkhan S and Schiemann WP: The lncRNA BORG Drives
Breast Cancer Metastasis and Disease Recurrence. Sci Rep.
7:126982017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ransohoff JD, Wei Y and Khavari PA: The
functions and unique features of long intergenic non-coding RNA.
Nat Rev Mol Cell Biol. 19:143–157. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Beermann J, Piccoli MT, Viereck J and Thum
T: Non-coding RNAs in development and disease: Background,
mechanisms, and therapeutic approaches. Physiol Rev. 96:1297–1325.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fang Y, Wang J, Wu F, Song Y, Zhao S and
Zhang Q: Long non-coding RNA HOXA-AS2 promotes proliferation and
invasion of breast cancer by acting as a miR-520c-3p sponge.
Oncotarget. 8:46090–46103. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang Y, Zhou J, Wang Z, Wang P and Li S:
Upregulation of SOX2 activated LncRNA PVT1 expression promotes
breast cancer cell growth and invasion. Biochem Biophys Res Commun.
493:429–436. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cho JY: Molecular diagnosis for
personalized target therapy in gastric cancer. J Gastric Cancer.
13:129–135. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Esteller M: Non-coding RNAs in human
disease. Nat Rev Genet. 12:861–874. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang S, Lan F and Xia Y: lncRA ANCR
inhibits non-small cell lung cancer Cell migration and invasion by
inactivating TGF-β pathway. Med Sci Monit. 24:6002–6009. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dong H, Wang W, Mo S, Chen R, Zou K, Han
J, Zhang F and Hu J: SP1-induced lncRNA AGAP2-AS1 expression
promotes chemoresistance of breast cancer by epigenetic regulation
of MyD88. J Exp Clin Cancer Res. 37:2022018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen IC, Lin HY, Hsiao YC, Chen CM, Wu YR,
Shiau HC, Shen YF, Huang KS, Su MT, Hsieh-Li HM and Lee-Chen GJ:
Internal ribosome entry segment activity of ATXN8 opposite strand
RNA. PLoS One. 8:e738852013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Koob MD, Moseley ML, Schut LJ, Benzow KA,
Bird TD, Day JW and Ranum LP: An untranslated CTG expansion causes
a novel form of spinocerebellar ataxia (SCA8). Nat Genet.
21:379–384. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fan CN, Ma L and Liu N: Systematic
analysis of lncRNA-miRNA-mRNA competing endogenous RNA network
identifies four-lncRNA signature as a prognostic biomarker for
breast cancer. J Transl Med. 16:2642018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Schnipper LE, Davidson NE, Wollins DS,
Tyne C, Blayney DW, Blum D, Dicker AP, Ganz PA, Hoverman JR,
Langdon R, et al: American Society of clinical oncology statement:
A conceptual framework to assess the value of cancer treatment
options. J Clin Oncol. 33:2563–2577. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang D, Zhu C, Zhang Y, Zheng Y, Ma F, Su
L and Shao G: MicroRNA-30e-3p inhibits cell invasion and migration
in clear cell renal cell carcinoma by targeting Snail1. Oncol Lett.
13:2053–2058. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Campos-Parra AD, López-Urrutia E, Orozco
Moreno LT, López-Camarillo C, Meza-Menchaca T, Figueroa González G,
Bustamante Montes LP and Pérez-Plasencia C: Long non-coding RNAs as
new master regulators of resistance to systemic treatments in
breast cancer. Int J Mol Sci. 19:E27112018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huang XJ, Xia Y, He GF, Zheng LL, Cai YP,
Yin Y and Wu Q: MALAT1 promotes angiogenesis of breast cancer.
Oncol Rep. 40:2683–2689. 2018.PubMed/NCBI
|
|
28
|
Wang G, Chen X, Liang Y, Wang W, Fang Y
and Shen K: Long noncoding RNA signature and disease outcome in
estrogen receptor-positive breast cancer patients treated with
tamoxifen. J Breast Cancer. 21:277–287. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang KC and Chang HY: Molecular mechanisms
of long noncoding RNAs. Mol Cell. 43:904–914. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang J, Yuan L, Zhang X, Hamblin MH, Zhu
T, Meng F, Li Y, Chen YE and Yin KJ: Altered long non-coding RNA
transcriptomic profiles in brain microvascular endothelium after
cerebral ischemia. Exp Neurol. 277:162–170. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Troy A and Sharpless NE: Genetic ‘lnc’-age
of noncoding RNAs to human disease. J Clin Invest. 122:3837–3840.
2012. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Courboulin A, Paulin R, Giguère NJ,
Saksouk N, Perreault T, Meloche J, Paquet ER, Biardel S, Provencher
S, Côté J, et al: Role for miR-204 in human pulmonary arterial
hypertension. J Exp Med. 208:535–548. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sacconi A, Biagioni F, Canu V, Mori F, Di
Benedetto A, Lorenzon L, Ercolani C, Di Agostino S, Cambria AM,
Germoni S, et al: miR-204 targets Bcl-2 expression and enhances
responsiveness of gastric cancer. Cell Death Dis. 3:e4232012.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ying Z, Li Y, Wu J, Zhu X, Yang Y, Tian H,
Li W, Hu B, Cheng SY and Li M: Loss of miR-204 expression enhances
glioma migration and stem cell-like phenotype. Cancer Res.
73:990–999. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chung TK, Lau TS, Cheung TH, Yim SF, Lo
KW, Siu NS, Chan LK, Yu MY, Kwong J, Doran G, et al: Dysregulation
of microRNA-204 mediates migration and invasion of endometrial
cancer by regulating FOXC1. Int J Cancer. 130:1036–1045. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Shen SQ, Huang LS, Xiao XL, Zhu XF, Xiong
DD, Cao XM, Wei KL, Chen G and Feng ZB: miR-204 regulates the
biological behavior of breast cancer MCF-7 cells by directly
targeting FOXA1. Oncol Rep. 38:368–376. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Flores-Pérez A, Marchat LA,
Rodríguez-Cuevas S, Bautista-Piña V, Hidalgo-Miranda A, Ocampo EA,
Martínez MS, Palma-Flores C, Fonseca-Sánchez MA, Astudillo-de la
Vega H, et al: Dual targeting of ANGPT1 and TGFBR2 genes by miR-204
controls angiogenesis in breast cancer. Sci Rep. 6:345042016.
View Article : Google Scholar : PubMed/NCBI
|
